Stage IIIB Cutaneous Melanoma AJCC v7 Active Not Recruiting Phase 3 Trials for Interferon alfa (DB05258)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0091048 (Stage IIIB Cutaneous Melanoma AJCC v7) | Active Not Recruiting | 3 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT02506153 | High-Dose Recombinant Interferon Alfa-2B, Ipilimumab, or Pembrolizumab in Treating Patients With Stage III-IV High Risk Melanoma That Has Been Removed by Surgery | Treatment | |
| NCT01274338 | Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage III-IV Melanoma That Has Been Removed by Surgery | Treatment |